Package details
Original BDPM fields are shown in French.
- Official name
- LOPINAVIR/RITONAVIR VIATRIS 200 mg/50 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 120 plaquette(s) thermoformée(s) OPA : polyamide orienté aluminium PVC-Aluminium de 1 comprimé(s)
- Marketing authorisation holder
- VIATRIS (IRLANDE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 Jul 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61708715CIP73006004CIP133400930060049Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LOPINAVIRcomprimé | 200 mg · un comprimé | SA |
| RITONAVIRcomprimé | 50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.